Later, Perdomo et al. analyzed by ctDNA sequencing 65 tumor mutations in 5 genes (TP53, NOTCH1, CDKN2A, CASP8, and PTEN) observing ctDNA alterations in 42% of plasma samples, with an overall concordance rate of 28%.23 This evidence concerns the gene CDKN2A and neoplasm.